Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [2621]

ELCC 2019: Studies give new insights on immunotherapy in elderly patients with advanced NSCLC

ELCC 2019: Studies give new insights on immunotherapy in elderly patients with advanced NSCLC

Single-cell sequencing reveals landscape of immune cell subtypes in lung cancer tumours

Single-cell sequencing reveals landscape of immune cell subtypes in lung cancer tumours

High-dose stereotactic body radiotherapy well-tolerated by patients with centrally located lung tumours

High-dose stereotactic body radiotherapy well-tolerated by patients with centrally located lung tumours

AACR 2019: Combo of virotherapy and radiotherapy shows early promise in patients with oesophageal cancer

AACR 2019: Combo of virotherapy and radiotherapy shows early promise in patients with oesophageal cancer

AACR 2019: Two KEYNOTE trials show pembrolizumab benefit for advanced SCLC

AACR 2019: Two KEYNOTE trials show pembrolizumab benefit for advanced SCLC

AACR 2019: Tarloxotinib promising against NRG1-fusion cancers

AACR 2019: Tarloxotinib promising against NRG1-fusion cancers

AACR 2019: Final results from early-phase lung cancer study show combination of Cuban immunotherapy and nivolumab is safe

AACR 2019: Final results from early-phase lung cancer study show combination of Cuban immunotherapy and nivolumab...

AACR 2019: Mesothelin-targeted CAR T-cell therapy shows early promise in patients with advanced solid tumours

AACR 2019: Mesothelin-targeted CAR T-cell therapy shows early promise in patients with advanced solid tumours

AACR 2019: Adding the MET inhibitor savolitinib to osimertinib beneficial for certain pretreated lung cancer patients

AACR 2019: Adding the MET inhibitor savolitinib to osimertinib beneficial for certain pretreated lung cancer...

Origin of resistance to lung cancer drug discovered

Origin of resistance to lung cancer drug discovered

More from ecancer